Short communication: HIV-1 gag genetic variation in a single acutely infected participant defined by high-resolution deep sequencing

AIDS Research and Human Retroviruses

Volumn 30, Issue 8, 2014, Pages 806-811

  Al Mawsawi, Laith Q ^a,b   Wu, Nicholas C ^a,b   De La Cruz, Justin ^a   Shi, Vivian Cai ^a   Wu, Ting Ting ^a,b   Daar, Eric S ^c   Lewis, Martha J ^a,b   Yang, Otto O ^a,b,d   Sun, Ren ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^d AIDS HEALTHCARE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ARTICLE; CD8+ T LYMPHOCYTE; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOLECULAR DYNAMICS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RNA SEQUENCE; ADAPTATION; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MOLECULAR GENETICS; VIROLOGY;

ADAPTATION, BIOLOGICAL; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 84905442673     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0097     Document Type: Article

References (31)

1. McMichael AJ, Borrow P, Tomaras GD, et al.: The immune response during acute HIV-1 infection: Clues for vaccine development. Nat Rev Immunol 2010;10(1): 11-23.
2. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al.: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122(8):573-579.
3. Mellors JW, Rinaldo CR Jr, Gupta P, et al.: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272(5265):1167-1170.
4. Carrington M and O'Brien SJ: The influence of HLA genotype on AIDS. Annu Rev Med 2003;54:535-551.
5. Fellay J, Shianna KV, Ge D, et al.: A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317(5840):944-947.
6. Gao X, Nelson GW, Karacki P, et al.: Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001;344(22):1668-1675.
7. Kulpa DA and Collins KL: The emerging role of HLA-C in HIV-1 infection. Immunology 2011;134(2):116-122.
8. Abrahams MR, Anderson JA, Giorgi EE, et al.: Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J Virol 2009;83(8):3556-3567.
9. Fischer W, Ganusov VV, Giorgi EE, et al.: Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 2010; 5(8):e12303.
10. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al.: Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 2008;105(21):7552-7557.
11. Salazar-Gonzalez JF, Salazar MG, Keele BF, et al.: Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 2009;206(6):1273-1289.
12. Ho DD, Neumann AU, Perelson AS, et al.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373(6510):123-126.
13. Levy DN, Aldrovandi GM, Kutsch O, et al.: Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci USA 2004;101(12):4204-4209.
14. Mansky LM: Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line. AIDS Res Hum Retroviruses 1996;12(4):307-314.
15. Mansky LM and Temin HM: Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995;69(8):5087-5094.
16. Perelson AS, Neumann AU, Markowitz M, et al.: HIV-1 dynamics in vivo: Virion clearance rate, infected cell lifespan, and viral generation time. Science 1996;271(5255): 1582-1586.
17. Rhodes T, Wargo H, and Hu WS: High rates of human immunodeficiency virus type 1 recombination: Near-random segregation of markers one kilobase apart in one round of viral replication. J Virol 2003;77(20):11193-11200.
18. Borrow P, Lewicki H, Hahn BH, et al.: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68(9):6103-6110.
19. Brumme ZL, Brumme CJ, Carlson J, et al.: Marked epi-tope-and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection. J Virol 2008;82(18):9216-9227.
20. Henn MR, Boutwell CL, Charlebois P, et al.: Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog 2012;8(3):e1002529.
21. Koup RA, Safrit JT, Cao Y, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68(7):4650-4655.
22. Wilson JD, Ogg GS, Allen RL, et al.: Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS 2000;14(3):225-233.
23. Kinde I, Wu J, Papadopoulos N, Kinzler KW, et al.: Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci USA 2011; 108(23):9530-9535.
24. Li H and Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25(14):1754-1760.
25. Balamurugan A, Lewis MJ, Kitchen CM, et al.: Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination. J Virol 2008;82(6):2784-2791.
26. Yang OO, Daar ES, Jamieson BD, et al.: Human immunodeficiency virus type 1 clade B superinfection: Evidence for differential immune containment of distinct clade B strains. J Virol 2005;79(2):860-868.
27. Yang OO, Daar ES, Ng HL, et al.: Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia. AIDS Res Hum Ret-roviruses 2011;27(4):391-398.
28. Jones NA, Wei X, Flower DR, et al.: Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med 2004;200(10):1243-1256.
29. Hedskog C, Mild M, Jernberg J, et al.: Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing. PLoS One 2010;5(7): e11345.
30. Li JZ, Chapman B, Charlebois P, et al.: Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy. PLoS One 2014; 9(3):e90485.
31. Wu NC, De La Cruz J, Al-Mawsawi LQ, et al.: HIV-1 quasispecies delineation by Tag linkage deep sequencing. PLoS One 2014;9(5):e97505.